Streptavidin-aequorin fusion protein for bioluminescent immunoassay

15Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The fusion protein of streptavidin to aequorin (STA-AQ) was highly purified from inclusion bodies in Escherichia coli cells and applied to a bioluminescent sandwich immunoassay. α-Fetoprotein (AFP), which is a serological marker of liver cancer, was used as a model analyte to test STA-AQ in an immunoassay. The measurable range of AFP by the sandwich immunoassay, using the complex of STA-AQ and the biotinylated anti-AFP antibody, was 0.02-200 ng/mL with an average coefficient of variation of 4.9%. The detection sensitivity with the complex of STA-AQ and the biotinylated anti-AFP antibody was similar to that with the complex of biotinylated aequorin, streptavidin and the biotinylated anti-AFP antibody. STA-AQ would be a useful reporter protein for immunoassays.

Cite

CITATION STYLE

APA

Inouye, S., Sato, J. I., Sasaki, S., & Sahara, Y. (2011). Streptavidin-aequorin fusion protein for bioluminescent immunoassay. Bioscience, Biotechnology and Biochemistry, 75(3), 568–571. https://doi.org/10.1271/bbb.100798

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free